Medacta Group SA
SIX:MOVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hexing Electrical Co Ltd
SSE:603556
|
CN |
|
Net Pacific Financial Holdings Ltd
SGX:5QY
|
SG |
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
CN |
|
Jiashili Group Ltd
HKEX:1285
|
CN |
|
T
|
Theriva Biologics Inc
AMEX:TOVX
|
US |
|
Xiaomi Corp
HKEX:1810
|
CN |
|
Meggitt PLC
LSE:MGGT
|
UK |
|
B
|
Bajaj Housing Finance Ltd
NSE:BAJAJHFL
|
IN |
|
Raymond James Financial Inc
NYSE:RJF
|
US |
|
S
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
HK |
|
R
|
Rumere Co Ltd
SZSE:301088
|
CN |
Medacta Group SA
Other Current Liabilities
Medacta Group SA
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Medacta Group SA
SIX:MOVE
|
Other Current Liabilities
€18m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Other Current Liabilities
CHf12.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-20%
|
|
|
Sonova Holding AG
SIX:SOON
|
Other Current Liabilities
CHf1.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Straumann Holding AG
SIX:STMN
|
Other Current Liabilities
CHf120.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Medmix Ltd
SIX:MEDX
|
Other Current Liabilities
CHf73.8m
|
CAGR 3-Years
47%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Medacta Group SA
Glance View
Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.
See Also
What is Medacta Group SA's Other Current Liabilities?
Other Current Liabilities
18m
EUR
Based on the financial report for Dec 31, 2025, Medacta Group SA's Other Current Liabilities amounts to 18m EUR.
What is Medacta Group SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-11%
Over the last year, the Other Current Liabilities growth was -7%. The average annual Other Current Liabilities growth rates for Medacta Group SA have been 5% over the past three years , -11% over the past five years .